Polo-Like Kinase 1(PLK1) Immunohistochemical Expression in Triple Negative Breast Carcinoma: A Probable Therapeutic Target

BACKGROUND: Breast cancer is the most commonly diagnosed female cancer and is a major cause of cancer-related deaths in women. Triple-negative breast cancer (TNBC) is defined as ER, PR and HER2 negative, which are characterized by rapid progression with low survival rates with limited therapeutic ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Salama, Maha E, Dina A, Dina A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080348/
https://www.ncbi.nlm.nih.gov/pubmed/34967572
http://dx.doi.org/10.31557/APJCP.2021.22.12.3921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080348/
https://www.ncbi.nlm.nih.gov/pubmed/34967572
http://dx.doi.org/10.31557/APJCP.2021.22.12.3921

Ejemplares similares